Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease

SIMPLE SUMMARY: Multiple myeloma is a cancer that remains incurable. Among the many therapies under evaluation, antibodies can be used as vehicles to target and deliver toxic radiation to the tumour cells. Our objective was therefore to investigate the potential of targeted alpha therapy, combining...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouard, Sébastien, Maurel, Catherine, Marionneau-Lambot, Séverine, Dansette, Delphine, Bailly, Clément, Guérard, François, Chouin, Nicolas, Haddad, Ferid, Alliot, Cyril, Gaschet, Joëlle, Eychenne, Romain, Kraeber-Bodéré, Françoise, Chérel, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564412/
https://www.ncbi.nlm.nih.gov/pubmed/32971984
http://dx.doi.org/10.3390/cancers12092721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564412/
https://www.ncbi.nlm.nih.gov/pubmed/32971984
http://dx.doi.org/10.3390/cancers12092721

Ejemplares similares